Concepts Associated with HCV Testing Hepatitis C virus core Ag [Presence] in Serum or Plasma by Immunoassay Hepatitis C virus core Ag [Units/volume] in Serum by Immunoassay Hepatitis C virus Ab [Presence] in Body fluid Hepatitis C virus Ab [Presence] in Body fluid by Immunoblot Hepatitis C virus Ab [Presence] in Cerebral spinal fluid Hepatitis C virus Ab Signal/Cutoff in Body fluid Hepatitis C virus core Ab+Ag [Presence] in Serum Hepatitis C virus genotype [Identifier] in Blood by NAA with probe detection Hepatitis C virus genotype [Identifier] in Serum or Plasma by NAA with probe detection Hepatitis C virus genotype [Identifier] in Tissue by NAA with probe detection Hepatitis C virus genotype [Identifier] in Unspecified specimen by NAA with probe detection Hepatitis C virus genotype 1 [Type] in Serum or Plasma by NAA with probe detection Hepatitis C virus genotype 1 NS5a gene mutations detected [Identifier] Hepatitis C virus genotype 1 NS5b gene mutations detected [Identifier] Hepatitis C virus genotype 3 [Presence] in Serum or Plasma by NAA with probe detection Hepatitis C virus genotype 3 NS5a gene mutations detected [Identifier] Hepatitis C virus genotype in Serum or Plasma by Sequencing Hepatitis C virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay Hepatitis C virus NS3 gene mutations detected [Identifier] by Genotype method Hepatitis C virus NS5 gene mutations detected [Identifier] by Genotype method Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection HCV antibody RIBA tests - Meaningful Use set by Immunoblot Hepatitis C virus 100+5-1-1 Ab [Presence] in Serum by Immunoblot Hepatitis C virus 100-3 Ab [Presence] in Serum by Immunoblot Hepatitis C virus 22-3 Ab [Presence] in Serum by Immunoblot Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot Hepatitis C virus Ab [Presence] in Serum by Immunoblot Hepatitis C virus Ab band pattern [Interpretation] in Serum by Immunoblot Hepatitis C virus c1 Ab [Presence] in Serum by Immunoblot Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum by Immunoblot Hepatitis C virus c2 Ab [Presence] in Serum by Immunoblot Hepatitis C virus c22p Ab [Presence] in Serum by Immunoblot Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot Hepatitis C virus E2 Ab [Presence] in Serum by Immunoblot Hepatitis C virus IgG Ab [Presence] in Serum by Immunoblot Hepatitis C virus IgG band pattern [Interpretation] in Serum by Immunoblot Hepatitis C virus NS3 Ab [Presence] in Serum by Immunoblot Hepatitis C virus NS4 Ab [Presence] in Serum by Immunoblot Hepatitis C virus NS5 Ab [Presence] in Serum by Immunoblot Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot HCV antibody screening - Meaningful Use set Hepatitis C virus 100-3 Ab [Presence] in Serum Hepatitis C virus 22-3 Ab [Presence] in Serum Hepatitis C virus 5-1-1 Ab [Presence] in Serum Hepatitis C virus Ab [Presence] in Serum Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay Hepatitis C virus Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay Hepatitis C virus Ab [Units/volume] in Serum Hepatitis C virus Ab [Units/volume] in Serum by Immunoassay Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay Hepatitis C virus c100p+5-1-1 Ab [Presence] in Serum Hepatitis C virus c33c Ab [Presence] in Serum Hepatitis C virus IgG Ab [Presence] in Serum Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay Hepatitis C virus IgG Ab [Units/volume] in Serum Hepatitis C virus IgG Ab [Units/volume] in Serum by Immunoassay Hepatitis C virus IgM Ab [Units/volume] in Serum Hepatitis C virus IgM Ab [Units/volume] in Serum by Immunoassay Hepatitis C virus superoxide dismutase Ab [Presence] in Serum HCV RNA screening tests - Meaningful Use set Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification Hepatitis C virus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification Hepatitis C virus RNA [Log #/volume] (viral load) in Unspecified specimen by NAA with probe detection Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification Hepatitis C virus RNA [log units/volume] (viral load) in Unspecified specimen by NAA with probe detection Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection Hepatitis C virus RNA [Presence] in Unspecified specimen by NAA with probe detection Hepatitis C virus RNA [Presence] in Unspecified specimen by Probe with signal amplification Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification Hepatitis C virus RNA [Units/volume] (viral load) in Unspecified specimen by NAA with probe detection Hepatitis C virus RNA panel (viral load) in Serum or Plasma by NAA with probe detection Antinuclear antibodies (ANA) Hepatitis C antibody Hepatitis C antibody; confirmatory test (eg, immunoblot) Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus Hepatitis C antibody Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
Concepts Associated with HCV Procedures RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) Hepatitis C screening documented as performed (HIV) Patient receiving antiviral treatment for Hepatitis C (HEP-C) Collection of venous blood by venipuncture Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver
Produced 06 Apr 2023